- $6.82m
- $5.14m
- $29.21m
Brief: Xwell, Inc. Plans To File Form 12B-25 To Extend Filing Date Of Its Form 10-K
Brief: Xwell Appoints Gaëlle Wizenberg To Its Board Of Directors
US CDC to expand surveillance of traveler samples for respiratory viruses (updated)
Brief: Ginkgo Bioworks And Xwell Implement Expand CDC Traveler-Based Genomic Surveillance Program To Test For More Than 30 Known Pathogens
US CDC to expand surveillance of travelers for respiratory viruses
Brief: Xwell Extends Collaboration With Centers For Disease Control & Prevention
Xwell Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: XWELL, Inc. Q2 revenue USD 8.2 million
Xwell Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Brief: Xwell Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing
Brief: XWELL Inc Appoints Suzanne Scrabis As Chief Financial Officer
Brief: Xwell Inc Announced That Suzanne A. Scrabis Has Been Appointed CFO
Brief: XWELL Says Valerie Lightfoot Did Not Commence As CFO On June 12
Brief: Xwell, Inc. Reports First Quarter 2023 Results
Xwell Inc Expected To Post A Loss Of 13 Cents A Share: Earnings Preview
Brief: Xwell, Inc. Names Valerie Lightfoot Chief Financial Officer
Brief: Xwell Announces Plans To File Form 12B-25 To Extend Filing Date Of Its Form 10-K And Provides Preliminary Fy2022 Operating Update
Xwell, Ginkgo rise after adding flu viruses to genomic surveillance program
Brief: XWELL Targets High Single-Digit Unit Growth Through 2025